Skip to content

Menu

Archives

  • February 2024
  • January 2024

Calendar

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Feb    

Categories

  • ALL
  • Ayurveda
  • Business
  • Entertainment
  • Health
  • Life Style
  • Science & Environment
  • Sports
  • Top Stories
  • World News

Copyright Information 2025 | Theme by ThemeinProgress | Proudly powered by WordPress

Information
You are here :
  • Home
  • Business
  • Hindalco Tanks 15% On Novelis’ Bay Minette Return Guidance; Buy, Sell Or Hold?
Written by Sanjeev Sharma14/02/2024

Hindalco Tanks 15% On Novelis’ Bay Minette Return Guidance; Buy, Sell Or Hold?

Business Article

[ad_1]

Last Updated: February 13, 2024, 13:16 IST

Hindalco tanks 15% post Novelis December quarter results

Shares of Hindalco Industries tanked 15 per cent to the day’s low of Rs 497.50 on the NSE

Hindalco Share Price: Shares of Hindalco Industries tanked 15 per cent to the day’s low of Rs 497.50 on the NSE on Tuesday after its US-based subsidiary Novelis lowered its returns guidance for Bay Minette project to double digits from an earlier mid-teens. Analysts believe that this would result in lower IRR (Internal Rate of Return).

“Fiscal year-to-date 2024 capital expenditures total $960 million, reflects the planned increase in strategic investments in new rolling and recycling capacity under construction,” Novelis, a subsidiary of Hindalco Industries, said.

On Monday, Novelis reported net income at $174 million which was up 81 per cent year-on-year (YoY) though it excluded special items, the company filing said. The adjusted EBITDA was reported at $454 million which was up 33 per cent YoY. The company reported net sales at $3.9 billion for the third quarter of fiscal year 2024, which decreased 6 per cent versus the prior year period driven by lower average aluminum prices as shipments were in line with prior year levels.

What Should Investors Do Now?

Kotak has recommended an ‘Add’ rating on Hindalco Industries for a price target of Rs 535. The brokerage has expressed a surprise on the Novelis—capex front. The December quarter earnings were in line with its estimates.

Novelis’ 3QFY24 adjusted EBITDA came in line with its estimates with the demand outlook improving in America, whereas Europe and Asia remain under pressure. The company has revised the capex outlay upward for its key growth project—greenfield expansion in North America — by 65 per cent to US$4.1 bn and delayed the timeline by one year to end FY2027E. Management has downgraded the return guidance from this project to ‘double digits’ from ‘mid-teens’ earlier. Cost inflation and delay do not impact our explicit earnings forecast until FY2026E, but damage the growth, earnings and return prospects of the company from a 5-year perspective, Nuvama said in a note.

JM Financial has maintained a buy view on the counter for a price target of Rs 610. The stock remains one of its preferred bets.

Novelis reported 3Q adjusted EBITDA of $454 mn which was higher than JM’s estimates of $437 mn. EBITDA outperformance was due to lower-than-expected raw material costs, it said in its stock review note.

The brokerage also highlighted key takeaways from the call which included a revision in its capex guidance for its Bay Minette plant from $2.7-2.8 bn to $4.1 bn, up 52 per cent.

Aparna Deb

Aparna Deb is a Subeditor and writes for the business vertical of News18.com. She has a nose for news that matters. She is inquisitive and curious abo…Read More

[ad_2]

Source link

You may also like

Redefining Returns: AIFs Reshaping Real Estate Investment Expectations

Crypto Currencies Have No Underlying Value, Says RBI Official

PACL Refund Status: Around 21 Lakh Investors Get Their Money Back, Says Sebi

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Archives

  • February 2024
  • January 2024

Calendar

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Feb    

Categories

  • ALL
  • Ayurveda
  • Business
  • Entertainment
  • Health
  • Life Style
  • Science & Environment
  • Sports
  • Top Stories
  • World News

Copyright Information 2025 | Theme by ThemeinProgress | Proudly powered by WordPress